Antimicrobial screening and molecular docking of synthesized 4,6-di(1H-indol-3-yl)-1,6-dihydropyrimidin-2-amine

Abstract

A variety of medicinal compounds, including 4,6-di(1H-indol-3-yl)-1,6-dihydropyrimidin-2-amine, were synthesized through a single-step, multicomponent, stepwise reaction. In this reaction, a mixture of 1H-indole-3-Carbaldehyde, 1-(1H-indol-3-yl) ethanone and guanidine nitrate in ethanol was refluxed. The synthesized compounds were characterized using ¹H NMR and ¹³C NMR studies and their antimicrobial activities against Escherichia coli, Staphylococcus aureus, Aspergillus niger and Aspergillus flavus were evaluated. Molecular docking analysis revealed specific amino acid residues (LEU704, GLY708, LEU707, GLN711, MET749, PHE764, VAL746, MET787, MET745, LEU873, HIS874, VA; 903, MET742, ILE898, MET895, ILE899, TRP741, THR877, P HE 876, LEU701, MET780) are involved in the interaction between androgen receptor and ligand. The optimal interaction and docking score were observed (7.0 kcal/mol).

Keywords

Aldehyde / Antimicrobial activity / Chalcone / Docking / 1H-indole-3-carbaldehyde

References

[1] Kumar D, Khan SI, Tekwani BL, Diwan PP, Rawat S. 4-Aminoquinoline–pyrimidine hybrids: synthesis, antimalarial activity, heme bindingand docking studies. Eur J Med Chem. 2015;89:490–502.

[2] Guo Y, Jing Li, Ma J, et al. Synthesisand antitumor activity of α-aminophosphonate derivatives containingthieno[2,3-d] pyrimidines. Chin Chem Lett. 2015;26:755–758.

[3] Judson RS, Kavlock RJ, Setzer RW, Hubal EA, Martin MT, Knudsen TB. Estimating toxicity-related biological Pathway altering dosesfor high-throughput chemical risk assessment. Chem Res Toxicol. 2011;24:451–462.

[4] Dionisio KL, Frame AM, Goldsmith MR, Wambaugh JF, Liddell A, Cathey T. Exploring consumer exposure pathways and patternsof use for chemicals in the environment. Toxicol Rep. 2015;2:228–237.

[5] Priya K, Setty M, Babu UV, Paiand KSR. Implications of EnvironmentalToxicants on ovarian follicles: how it can adversely affect the female fertility? Environ Sci Pollut Res Int. 2021;28:67925–67939.

[6] Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM. In vitro screening of EnvironmentalChemicals for targeted testing prioritization. The ToxCast Project.Environ. Health Perspect. 2010;118:485–492.

[7] Yilmaz B, Terekeci H, Sandal S, Kelestimur F. EndocrineDisrupting chemicals: exposure, effects on human health, mechanism ofAction, models for testing and strategies for prevention. Rev Endocr Metab Disord. 2020;21:127–147.

[8] Tickner J, Jacobs M, Malloy T, Buck T, Stone A, Blake A. AdvancingAlternatives assessment for safer chemical substitution: a research and PracticeAgenda. Integrated Environ Assess Manag. 2019;15:855–866.

[9] Parthasarathi R. In silico approaches for predictive Toxicology. In Vitro Toxicol. 2018: 91–109.

[10] Rabinowitz JR, Goldsmith MR, Little SB, Pasquinelli MA. Computational Molecular Modeling forevaluating the toxicity of environmental chemicals: prioritizing bioassay requirements. Environ Health Perspect. 2008;116:573–576.

[11] Al Sharif M, Tsakovska I, Pajeva I, et al. The application of molecular modelling in the safety assessment ofchemicals: a case study on ligand-dependent PPAR dysregulation. Toxicology. 2017;392:140–154.

[12] OECD. Guidance Document on Developing and Assessing Adverse Outcome Pathways. Vol. 184. Paris, France: OECD; 2013.

[13] Elshan NGRD, Rettig MB, Jung ME. Molecules targeting the androgen receptor (AR) signaling axis beyond the ARLigandbinding domain. Med Res Rev. 2019;39:910–960.

[14] Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms ofcastrate resistance and novel therapeutic approaches. Oncogene. 2013;32:5501–5511.

[15] Chandrasekar T, Yang JC, Gao AC, Evans CP. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Transl Androl Urol. 2015;4:365–380.

[16] Ramadevi S, Sivaranjani S, Murugesan R, Kaleeswaran B. Assessment of anti-microbial activity by the green synthesised silver nanoparticles of different parts of Plumbago zeynalica L. Plant. Intern. J. Zool. Invest. 2023;9(1):224–232.

[17] Murugesan R, Vasuki K, Ramadevi S, Kaleeswaran B. Rosmarinic acid: Potential antiviral agent against dengue virus - In silico evaluation, Intelligent Pharmacy, https://doi.org/10.1016/j.ipha.2023.12.006.

[18] Murugesan R, Vasuki K, Kaleeswaran B. A green alternative: evaluation of Solanum torvum (Sw) leaf extract of Aedes aegypti (L) and its molecular docking potential. Int Pharmacop. 2023.

[19] Samy Christy Rani Arokia, Karunanithi Kalaimathi, Sheshadhri Jayasree, Rengarajan Murugesan, Srinivasan Prabhu. Pinkie cherian. (R)^- (+)^- rosmarinic acid as an inhibitor of herpes and dengue virus replication: an in silico assessment. Rev Bra deFar. 2023;33:543–550.

[20] Liu N, Zhou WF, Guo Y, et al. Molecular dynamics simulations revealed the regulation of ligands to the interactionsbetween androgen receptor and its coactivator. J Chem Inf Model. 2018;58:1652–1661.

[21] Azhagiya Singam ER, Tachachartvanich P, La Merrill MA, Smith MT, Durkin KA. Structural dynamics of agonist and antagonist binding to the androgen receptor. J Phys Chem B. 2019;123:7657–7666.

[22] Liu H, Wang L, Tian J, Li J, Liu H. Molecular dynamics studies on the enzalutamide resistance mechanisms induced by androgen receptor mutations. J Cell Biochem. 2017;118:2792–2801.

[23] Kang IH, Kim HS, Shin JH, et al. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p’-DDE in rodent 10-day Hershberger assay. Toxicology. 2004;199:145–159.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.